New
Arrivals/Restock
Phase II Clinical Development of New Drugs (ICSA Book Series in Statistics)
4.2 (25 items)
Limited Time SaleUntil the end
08
58
41
$38.03 cheaper than the new price!!
Free shipping for purchases over $99 ( Details )
Free cash-on-delivery fees for purchases over $99
Free cash-on-delivery fees for purchases over $99
See all stores
Please note that the sales price and tax displayed may differ between online and in-store. Also, the product may be out of stock in-store.
New $63.38
Product details
| Management number | 231846666 | Release Date | 2026/06/18 | List Price | $25.35 | Model Number | 231846666 | ||
|---|---|---|---|---|---|---|---|---|---|
| Category | |||||||||
This book focuses on how to appropriately plan and develop a Phase II program, and how to design Phase II clinical trials and analyze their data. It provides a comprehensive overview of the entire drug development process and highlights key questions that need to be addressed for the successful execution of Phase II, so as to increase its success in Phase III and for drug approval. Lastly it warns project team members of the common potential pitfalls and offers tips on how to avoid them. Read more
| ASIN | B073H76FJG |
|---|---|
| XRay | Not Enabled |
| Format | Print Replica |
| ISBN13 | 978-9811041945 |
| Edition | 1st ed. 2017 |
| Language | English |
| File size | 4.9 MB |
| Page Flip | Not Enabled |
| Publisher | Springer |
| Word Wise | Not Enabled |
| Print length | 258 pages |
| Accessibility | Learn more |
| Part of series | ICSA Book Series in Statistics |
| Publication date | April 8, 2017 |
| Enhanced typesetting | Not Enabled |
Correction of product information
If you notice any omissions or errors in the product information on this page, please use the correction request form below.
Correction Request Form